Abstract

Loss of podocytes is a hallmark of diabetic nephropathy, and a growing body of evidence indicates that podocytes are susceptible to palmitic acid (PA). We have previously shown that AS-IV inhibited PA-induced podocyte apoptosis by activating sarcoendoplasmic reticulum Ca2+ ATPase (SERCA), which indicate calcium regulation may involve in the process. Immunofluorescence staining, Western blot and flow cytometry were used to measure the protective efficacy of AS-IV to ameliorate PA-induced ER stress and podocyte apoptosis. Meanwhile, AS-IV inhibited cytochrome c release, decreased mitochondrial membrane potential, accompany with the depletion of endoplasmic reticulum Ca2+ and elevation of cytosolic and mitochondrial Ca2+. Sequestration of cytosolic calcium with BAPTA-AM limited the response of podocyte apoptosis, while during the process the effect of AS-IV was also restrained. In contrast, elevation of cytosolic calcium with calcium ionophore ionomycin was depressed by AS-IV addition. Furthermore, inhibiting TRPC6 expression with SKF96365 or TRPC6 siRNA counteracted the beneficial effect of AS-IV. Our study provides further evidence to conclude the inhibitory effect of AS-IV to podocyte apoptosis is Ca2+-dependent. And the efficacy correlates with inhibiting TRPC6-mediated Ca2+ influx, and then cellular Ca2+ disturbance was coordinated.

Highlights

  • Podocytes are terminally differentiated epithelial cells in the filtration barrier of the kidney

  • Our previous investigation showed that Astragaloside IV (AS-IV) treatment could ameliorate podocyte injury via sarcoendoplasmic reticulum ­Ca2+ ATPase 2 (SERCA2)-dependent ER stress reduction, which indicates that ­Ca2+ may take part in the regulatory role of AS-IV on podocyte apoptosis [13, 14]

  • To evaluate the anti-apoptosis activity of AS-IV, podocytes were exposed to palmitic acid (PA) and AS-IV at the indicated concentrations

Read more

Summary

Introduction

Podocytes are terminally differentiated epithelial cells in the filtration barrier of the kidney. The class C transient receptor potential (TRPC) channels are C­ a2+-permeable cation channels expressed in the plasma membrane of a large amount of tissue and cell type including kidney [6]. Astragaloside IV (AS-IV) is a representative saponin isolated from Astragalus membranaceus (Fisch) Bge, which possesses various pharmacological activities such as inhibiting fibrosis, oxidative stress and apoptosis in kidney disease [10,11,12]. Our previous investigation showed that AS-IV treatment could ameliorate podocyte injury via sarcoendoplasmic reticulum ­Ca2+ ATPase 2 (SERCA2)-dependent ER stress reduction, which indicates that ­Ca2+ may take part in the regulatory role of AS-IV on podocyte apoptosis [13, 14]. We further showed that ­Ca2+ homeostasis was disrupted with the administration of palmitic acid (PA), accompanied with the ascending cytochrome c release and mitochondrial membrane potential. The efficacy of AS-IV linking with PA-induced ER stress and apoptosis in mouse podocyte was determined, and the mechanism relative to TRPC6 was been investigated

Material and methods
Results
Discussion
Compliance with ethical standards

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.